课题基金 / 基金详情

项目摘要

项目成果

KENNETH D ALDAPE的其他基金

相似基金

相关文献

中文摘要
翻译
病理学和组织采购核心的具体目标是: 目标1维护和增强肿瘤组织和匹配血液样本的存储库 中枢神经系统(CNS)肿瘤患者在加州大学接受治疗 德克萨斯州安德森癌症中心(UTMDACC)。 目的2提供孢子所用组织样本的全面组织学特征 项目,包括患者标本和动物实验性肿瘤; 尽快将组织样本分发给孢子调查员进行分析;并提供 对对孢子内组织切片进行的研究进行解释的专门知识 项目。 目标3提供集中服务,包括生物标记物的免疫组织化学表征, 组织阵列的设计和构建,以及肿瘤样本的原代培养 恰如其分。 目标4支持一个全面的、前瞻性的交互数据库,其中包含详细的临床和 在UTMDACC接受护理或评估的中枢神经系统肿瘤患者的病理数据。 目的5通过共享组织资源促进孢子间的协作。
英文摘要
The specific objectives of the Pathology and Tissue Procurement Core are to: Objective 1 Maintain and enhance a repository of tumor tissue and matched blood specimens from patients with central nervous system (CNS) tumors receiving care at The University of Texas M. D. Anderson Cancer Center (UTMDACC). Objective 2 Provide comprehensive histologic characterization of tissue samples used in the SPORE Projects, including specimens from patients and experimental tumors in animals; expeditiously distribute tissue specimens to SPORE investigators for analysis; and provide expertise in the interpretation of studies performed on tissue sections within the SPORE Projects. Objective 3 Offer centralized services, including immunohistochemical characterization of biomarkers, tissue array design and construction, and primary culture of tumor samples where appropriate. Objective 4 Support a comprehensive, prospective interactive database with detailed clinical and pathologic data for patients with CNS tumors receiving care or evaluation at UTMDACC. Objective 5 Facilitate inter-SPORE collaborations through sharing of tissue resources.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TOWARDS A REFINED MOLECULAR RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOM
  • 批准号:
    7944134
  • 项目类别:
  • 资助金额:
    $102.0万
  • 财政年份:
    2009
  • 负责人:
    KENNETH D ALDAPE
  • 依托单位:
TOWARDS A REFINED MOLECULAR RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOM
  • 批准号:
    7853814
  • 项目类别:
  • 资助金额:
    $103.65万
  • 财政年份:
    2009
  • 负责人:
    KENNETH D ALDAPE
  • 依托单位:
Predictive Markers to Personalize Medicine for Malignant Glioma
Pathology and Biorepository Core
海外基金